Low volume and price is still below the post news gap high. I'd say the stock has just finished churning through most of the opportunistic sellers.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025